STAT+: ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure
Reported by STAT News · all stories from statnews.com
Editorial digest
The Advanced Research Projects Agency for Health (ARPA-H) is committing $62 million to develop artificial intelligence tools. These tools aim to assist in treating heart failure and will seek FDA authorization.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Reputable trade press8/20/2026
FDA-cleared medical AI rarely tested for real-world benefits - News-Medical
FDA-cleared medical AI often lacks real-world benefit testing.
- Reputable trade press8/19/2026
Nearly All FDA-Cleared AI Medical Devices Lack Evidence of Patient Benefit - Inside Precision Medicine
Most FDA-approved AI medical devices lack strong evidence of direct patient benefit.
- Official source8/19/2026
Most AI medical devices cleared for use were not tested on patient outcomes - EurekAlert!
Many AI medical devices approved lacked patient outcome testing.
- Reputable trade press8/19/2026
Most AI medical devices cleared for use were not tested on patient outcomes - Medical Xpress
Most cleared AI medical devices lacked patient outcome testing.
- Official source7/23/2026
Digital Health Technologies (DHTs) for Drug Development - fda.gov
The FDA issued guidance on Digital Health Technologies for drug development.
- Trusted health newsroom9/3/2026
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
FDA pilot program allows generative AI devices to reach patients pre-authorization.